XENLETA Trademark

Trademark Overview

On Monday, July 8, 2019, a trademark application was filed for XENLETA with the United States Patent and Trademark Office. The USPTO has given the XENLETA trademark a serial number of 88503355. The federal status of this trademark filing is REGISTERED as of Tuesday, January 26, 2021. This trademark is owned by Nabriva Therapeutics US, Inc.. The XENLETA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating respiratory illnesses; antibiotics; anti-infectives; pharmaceutical preparations for the treatment of pneumonia and bacterial infections
xenleta

General Information

Serial Number88503355
Word MarkXENLETA
Filing DateMonday, July 8, 2019
Status700 - REGISTERED
Status DateTuesday, January 26, 2021
Registration Number6257822
Registration DateTuesday, January 26, 2021
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 31, 2020

Trademark Statements

Description of MarkThe mark consists of two concentric square designs, which overlap. A shaded square is positioned on top of the overlapping portion of the two concentric square designs. Immediately to the right is the stylized wording, "XENLETA".
Goods and ServicesPharmaceutical preparations for treating respiratory illnesses; antibiotics; anti-infectives; pharmaceutical preparations for the treatment of pneumonia and bacterial infections
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 15, 2019
Primary Code005
First Use Anywhere DateSaturday, August 31, 2019
First Use In Commerce DateSaturday, August 31, 2019

Trademark Owner History

Party NameNabriva Therapeutics US, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFort Washington, PA 19034
Party NameNabriva Therapeutics US, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKing of Prussia, PA 19406
Party NameNabriva Therapeutics US, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKing of Prussia, PA 19406

Trademark Events

Event DateEvent Description
Sunday, September 15, 2019ASSIGNED TO EXAMINER
Thursday, July 11, 2019NEW APPLICATION ENTERED
Monday, July 15, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 16, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, September 17, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 17, 2019NON-FINAL ACTION WRITTEN
Tuesday, September 17, 2019NON-FINAL ACTION E-MAILED
Wednesday, October 30, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 30, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 30, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 20, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 20, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 20, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 20, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 20, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 21, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 19, 2020TEAS AMENDMENT OF USE RECEIVED
Wednesday, February 19, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 19, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 19, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 21, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, February 22, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 21, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 24, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 31, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 11, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 31, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 26, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 2, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 23, 2020TEAS STATEMENT OF USE RECEIVED
Monday, November 23, 2020USE AMENDMENT FILED
Wednesday, December 2, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, December 23, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 22, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 26, 2021REGISTERED-PRINCIPAL REGISTER
Friday, August 20, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, August 20, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, August 20, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 20, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 20, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 20, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 4, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 4, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 4, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 12, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 12, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, October 4, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 4, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 12, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

xenleta pharmaceutical preparations pneumonia treatment bacterial infections infectives antibiotics treating respiratory